OTC: COGZF - Cogstate Limited

Rentabilité sur six mois: +40.35%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Cogstate Limited

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Cogstate Limited

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments.

plus de détails
The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Industry Health Care Technology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.cogstate.com
Цена ао 0.84
Changement de prix par jour: 0% (0.8)
Changement de prix par semaine: -6.98% (0.86)
Changement de prix par mois: +14.29% (0.7)
Changement de prix sur 3 mois: +25% (0.64)
Changement de prix sur six mois: +40.35% (0.57)
Changement de prix par an: +1.27% (0.79)
Evolution du prix sur 3 ans: -36.51% (1.26)
Evolution du prix sur 5 ans: +155.18% (0.3135)
Evolution des prix sur 10 ans: 0% (0.8)
Evolution des prix depuis le début de l'année: +26.98% (0.63)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 2.87 6
P/BV 3.05 5
P/E 22.88 6
EV/EBITDA 0 0
Total: 6.13

Efficacité

Nom Signification Grade
ROA, % 9.74 3
ROE, % 13.87 4
Total: 2.83

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 25.88 4
Rentabilité Ebitda, % -221.06 0
Rentabilité EPS, % -382.41 0
Total: 0.8
Plus de détails

Établissements Volume Partager, %
Bard Financial Services, INC. 12500 0.01



Superviseur Titre d'emploi Paiement Année de naissance
Prof. Paul Maruff BBSc (Hons), Ph.D. Founder & Chief Innovation Officer N/A
Mr. Darren Watson Chief Financial Officer 356.18k
Mr. Kenneth Billard Chief Commercial Officer 417.18k
Ms. Rachel Colite Executive VP of Clinical Trials 290.87k
Ms. Kristi Geddes General Counsel, Joint Company Secretary & Director N/A
Mr. David James Franks BEc, C.A., F Fin, J.P. Joint Company Secretary N/A 1970 (55 années)
Mr. Bradley John O'Connor B.Bus, C.A., CA CEO, MD & Executive Director

Adresse: Australia, Melbourne. VIC, 367 Collins Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.cogstate.com